Nalaganje...
Pre-treatment protoporphyrin IX concentration in actinic keratosis lesions may be a predictive biomarker of response to aminolevulinic-acid based photodynamic therapy
BACKGROUND: Although Aminolevulinic Acid (ALA)-induced protoporphyrin IX (PpIX) photodynamic therapy (PDT) is an effective FDA-approved therapy for actinic keratosis (AK), a substantial fraction of patients (up to 25%) do not respond to treatment. This study examined the feasibility of using pre-tre...
Shranjeno v:
| izdano v: | Photodiagnosis Photodyn Ther |
|---|---|
| Main Authors: | , , , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
2015
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4684466/ https://ncbi.nlm.nih.gov/pubmed/26480810 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.pdpdt.2015.10.006 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|